Advertisement

Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnerships 600x60px

Persons > All

Please find below persons from Ireland & the United Kingdom (GB) or related to organisations from these countries.

Total search results: 3463 | Ordered by Organisation (Group) (ascending)
1 2 3 ... 33 34 35  next pagenext page

order ascendingorder descendingPerson order ascendingorder descendingPosition order ascendingorder descendingOrganisation (Group) order ascendingorder descendingRegion
Bonislawski, Adam Editor / Publisher
Calikowski, Tomasz (EU 201403 Scientific Officer of European Commission) Administrative Officer (personnel)
Clemens, Ralf (CureVac 201603 SAB + Supervisory Board Member before GSK Biologicals + Novartis) scientific advisory board (SAB)
Dawson, Mike (Cantab Anti-Infectives + Novacta Biosystems before GSK) n. a.
Edick, Paul R. (3G Advisors 201603 Founding Partner) Company Founder
Feling, Nicole (Köhl et Feling 201310 Partner + Bicoll PR) Public Relations Manager / Investor Relations Manager Hessen (federal state)
Fiorentino, Ed (TerSera Therapeutics 201602– CEO before 22y veteran at Abbott) Chief Executive Officer (CEO)
Gunn, George (Stonehaven Consulting 201701 CEO + Founder before CEO Novartis Animal Health + UK Agri Ministry) Chief Executive Officer (CEO)
Hansen-Luke, Douglas (Future Planet Capital 201704 Executive Chairman) Board member, executive
Mortlock, Andrew (AstraZeneca 201604 VP Global Projects + Alliances at AstraZeneca Oncology iMed) President/Director/Head Business Group/Unit/Division
Oostdyk, Timothy S. (Eurofins 201606 Chairman Eurofins Lancaster Labs + Group SVP BioPharma Product Testing) n. a.
Phippen, Peter (Immediate Media 201501 Director) President/Director/Head Business Group/Unit/Division
Sehgal, Raman (Ramarketing & PR Ltd 2009– Managing Director + Founder) Managing Director
Stamatoyannopoulos, John A. (Altius Institute 201606– Head of Institute before Prof at Univ Washington) President/Director/Head of Research Organisation/Unit
Summerton, Linda (Immodulon Therapeutics 201702 CEO + TranScrip before Merck KGaA + AstraZeneca) Chief Executive Officer (CEO)
Testa, Bernard Professor
Uhlén, Mathias (Royal Institute of Technology (SE) 201509 Professor of Microbiology) Professor
Schafer, Alan (14M Genomics 201507– CEO before Population Genetics + Wellcome Trust + Hexagen + GSK) Chief Executive Officer (CEO) 14M Genomics Ltd. (14MG) East of England (region)
Budwick, Dan (1AB Media 201704– Founder before Pure Communications) Public Relations Manager / Investor Relations Manager 1AB Media (Dan Budwick) Florida (federal state)
Doppler, Clemens (3i Germany 2007 Director Healthcare Team) Investment Manager 3i (Group) Hessen (federal state)
Friese, L. n. a. 3i (Group) Bayern (federal state)
Peyton, Duncan Joseph (4D Pharma 201602 CEO + major shareholder) Chief Executive Officer (CEO) 4D Pharma (Group) Yorkshire and the Humber (region)
Danhauser-Riedl, Susanne (4SC 201401– CMO before GSK GmbH + MedacSchering Onkologie GmbH) Chief Medical Officer (CMO) 4SC (Group) Bayern (federal state)
Loveridge, Jason (4SC 201609– CEO) Chief Executive Officer (CEO) 4SC (Group) Bayern (federal state)
Rocklage, Scott M. (5AM Ventures 201603 Managing Partner + Founder) Managing Partner (investment firm) 5AM Ventures California (federal state)
Kenneweg, John (908 Devices 201503 VP Sales) Sales Manager / Marketing Manager 908 Devices Inc. Massachusetts (federal state)
Knopp, Kevin J. (908 Devices 201303 CEO + Co-founder before Thermo Fisher + Ahura Scientific) Chief Executive Officer (CEO) 908 Devices Inc. Massachusetts (federal state)
Gales, Ann (A Gales Consulting 201709 Managing Partner) Managing Partner A Gales Consulting Ltd. Greater London (region)
Gonzalez, Richard A. (Abbott 201110 EVP Global Pharmaceuticals before COO) President/Director/Head Business Group/Unit/Division Abbott (Group) Illinois (federal state)
O'Kelly, Stafford (Abbott 200803 VP Molecular Diagnostics) n. a. Abbott (Group) Illinois (federal state)
O’Kelly, Stafford (Abbott 200812 VP Molecular Diagnostics) n. a. Abbott (Group) United States (USA)_o
White, Miles D. (Abbott 200611 CEO) Chief Executive Officer (CEO) Abbott (Group) Illinois (federal state)
Baker, John (Abcam 201807 SVP Portfolio + Business Development) Business Development Manager / Strategy Manager Abcam (Group) East of England (region)
Harter, Dr. (Abcam 200808 Senior BusDev Manager) Business Development Manager / Strategy Manager Abcam (Group) East of England (region)
Hirzel, Alan (Abcam 201409– CEO before Chief Marketing Officer) Chief Executive Officer (CEO) Abcam (Group) East of England (region)
Iliffe, Jeff (Abcam 201401 CFO) Chief Financial Officer (CFO) Abcam (Group) East of England (region)
Milner, Jonathan (Abcam 201409 Deputy Chairman + largest shareholder before CEO + Co-founder) Chief Executive Officer (CEO) Abcam (Group) East of England (region)
Newman, Kasia (Abcam 200910 European Marketing Coordinator) Sales Manager / Marketing Manager Abcam (Group) East of England (region)
Yu, Guo-Liang (Epitomics 201105 CEO) Chief Executive Officer (CEO) Abcam (Group) California (federal state)
Barnes, Julie (Abcodia 201105 CEO before BioWisdom 200602 CSO) Chief Executive Officer (CEO) Abcodia Ltd. Greater London (region)
Carvell, John (Aber Instruments 201302 Sales + Marketing Director) Sales Manager / Marketing Manager Aber Instruments Ltd. Wales
Maurer, Karl-Heinz (ABF 201101– BusDev AB Enzymes GmbH before Henkel KGaA Corporate Director Biotechnology) Business Development Manager / Strategy Manager ABF (Group) Hessen (federal state)
Moelker, Adriaan (ABF 201105 Managing Director of AB Enzymes GmbH) Managing Director ABF (Group) Hessen (federal state)
Ellingworth, Peter (ABHI 201101 CEO) Chief Executive Officer (CEO) ABHI (Association of British Healthcare Industries) Greater London (region)
Sprance, Jennifer (Jen) (ABI Marketing Public Relations 201107 Global Director Life Sciences ABI Europe) President/Director/Head Business Group/Unit/Division ABI Inc. (Marketing Public Relations) Greater London (region)
Hand, Chris (Abingdon Health 201206 CEO) Chief Executive Officer (CEO) Abingdon Health (Group) Yorkshire and the Humber (region)
Yates, Chris (Abingdon Health 201710 CEO) Chief Executive Officer (CEO) Abingdon Health (Group) Yorkshire and the Humber (region)
Berriman, John (Abingworth) n. a. Abingworth (Group) Greater London (region)
Bigham, Michael F. (Abingworth 200611 Partner) n. a. Abingworth (Group) Greater London (region)
Bunting, Stephen (Abingworth 200701 Managing Director) Managing Director Abingworth (Group) Greater London (region)
Haines, Timothy (Tim) (Abingworth 201507– Managing Partner joined 2005 before Astex CEO) Partner (venture partner) Abingworth (Group) Greater London (region)
Heard, John (Abingworth Management 200610 General Counsel before Intel Capital) General Counsel / Chief Legal Officer (CLO) Abingworth (Group) Greater London (region)
Leathers, David n. a. Abingworth (Group) Greater London (region)
Lloyd-Harris, Genghis (Abingworth 201402 Partner) Partner (venture partner) Abingworth (Group) Greater London (region)
Sandham, Andrew (Andy) (Abingworth 200601– Venture Partner + Kymab 201007 CEO) Venture Partner Abingworth (Group) Greater London (region)
Stewart, Victoria (Abingworth 2000– Principal Public Relations before PJB Publications / Scrip) Public Relations Manager / Investor Relations Manager Abingworth (Group) Greater London (region)
von Emster, Kurt (Abingworth 201507– Managing Partner joined 201501 before venBio + MPM Capital + Franklin Templeton) Partner (venture partner) Abingworth (Group) California (federal state)
Ehrlich, Hartmut J. (Abivax 201410 CEO before Baxter BioScience 200712 VP Global RnD) Chief Executive Officer (CEO) Abivax (Group) Île-de-France (region)
Lizarraga, Raquel (Abivax 201511 Investor Relations before Carbios + Altamir + PepsiCo) Public Relations Manager / Investor Relations Manager Abivax (Group) Île-de-France (region)
Pearce, Alexandra (Abivax 201805– VP Regulatory Affairs before Viramal + Glenmark UK + Amgen + Pfizer) Regulatory Affairs Manager Abivax (Group) Île-de-France (region)
Brooks, David (Ablatus Therapeutics 201607 CEO before TwistDx/Alere) Chief Executive Officer (CEO) Ablatus Therapeutics Ltd. United Kingdom (state/region unspecified)
Heylen, Johan (Ablynx 201411– CCO before GSK + Servier + Wyeth) Chief Commercial Officer (CCO) Ablynx (Group) Flanders (Flemish region)
Holz, Josefin-Beate (Josi) (Ablynx 200708– CMO) Chief Medical Officer (CMO) Ablynx (Group) Flanders (Flemish region)
Menrad, Andreas (Ablynx 201211 CSO) Chief Scientific Officer (CSO) / Chief Development Officer (CDO) Ablynx (Group) Flanders (Flemish region)
Moses, Edwin (Ablynx 200603– CEO before non-exec Board Member 200411– before Oxford Asymmetry) Chief Executive Officer (CEO) Ablynx (Group) Flanders (Flemish region)
Schneider, Daniel (Dan) (Ablynx 201710 General Manager at Ablynx Inc before BTG International Inc) General Manager (management) Ablynx (Group) United States (USA)_o
Barker, Richard (ABPI 201101 Director General) General Manager (management) ABPI (Association of the British Pharmaceutical Industry) Greater London (region)
Gaymond, Nigel (BioIndustry Association 201001– Chief Executive) Chief Executive Officer (CEO) ABPI (Association of the British Pharmaceutical Industry) Greater London (region)
Whitehead, Stephen (ABPI 201211 Chief Executive) Chief Executive Officer (CEO) ABPI (Association of the British Pharmaceutical Industry) Greater London (region)
Hutchings, Nick (Absolute Antibody Ltd 201404 CEO) Chief Executive Officer (CEO) Absolute Antibody Ltd. South East England (region)
Baker, Matthew (Matt) (Antitope 201301 CEO + Co-founder) Chief Executive Officer (CEO) Abzena (Group) East of England (region)
Brocchini, Steve (PolyTherics 201105 CSO + Co-founder) Chief Scientific Officer (CSO) / Chief Development Officer (CDO) Abzena (Group) Greater London (region)
Bunce, Campbell (Abzena 201511– SVP Scientific Operations before Oxford Immunotec + Immune Targeting Systems) Chief Scientific Officer (CSO) / Chief Development Officer (CDO) Abzena (Group) Greater London (region)
Burt, John (Abzena 201405– CEO before Antitope + PolyTherics + Thiakis) Chief Executive Officer (CEO) Abzena (Group) Greater London (region)
Jain, Naresh (The Chemistry Research Solution 201511 Managing Director) Managing Director Abzena (Group) Pennsylvania (federal state)
Mistry, Ajay (PolyTherics 201201 Business Development Manager) Business Development Manager / Strategy Manager Abzena (Group) Greater London (region)
Powell, Keith (PolyTherics 2006–201105 CEO LEFT 5/11) Chief Executive Officer (CEO) Abzena (Group) Greater London (region)
Smith, Julian (PolyTherics 201309– CFO before Imperial Innovations + RadioScape) Chief Financial Officer (CFO) Abzena (Group) Greater London (region)
Hornstein, Jörg (AC Immune 201701– CFO before Theo Müller Group + Merck KGaA) Chief Financial Officer (CFO) AC Immune S.A. (Nasdaq: ACIU) Région Lémanique (region)
Gilbert, Julian (Acacia Pharma Ltd 201309 CEO) Chief Executive Officer (CEO) Acacia Pharma (Group) East of England (region)
Soden, Christine (Acacia Pharma 201507– CFO joined 201502 before Celltech-Chiroscience + BTG + Optos + Medeva + Oxagen) n. a. Acacia Pharma (Group) East of England (region)
Molyneux, Norman (Acceleris Ltd 201201 CEO) Chief Executive Officer (CEO) Acceleris Ltd. North West England (region)
d’Hauteville, Guillaume (Access Industries 201710 Vice Chairman) n. a. Access Industries (Group) New York (federal state)
Liemen, Marcus (Accurion GmbH 201602 Managing Director) Managing Director Accurion (Group) Niedersachsen (federal state)
Cook, David (Biotie 201302– CFO before Jazz Pharma/EUSA Pharma CFO + Zeneus Pharma) Chief Financial Officer (CFO) Acorda Therapeutics (Group) Länsi-Suomi
Greenwood, David (Synosis 200701– European Director of Clinical Science before Shire + Zeneca + ICI) n. a. Acorda Therapeutics (Group) Northwestern Switzerland (region)
Nurmi, Virve (Biotie 201110 Investor Relations Manager) Public Relations Manager / Investor Relations Manager Acorda Therapeutics (Group) Länsi-Suomi
Veromaa, Timo (BioTie 1998– VP RnD promoted CEO 5/05 before Schering Oy before Collagen Corp) Chief Executive Officer (CEO) Acorda Therapeutics (Group) Länsi-Suomi
Tzouvalis, Plato (Acrongenomics 200704 President) n. a. Acrongenomics Inc. Greater London (region)
Nathrath, Daniel (Ada Health 201712 CEO + Co-Founder) Chief Executive Officer (CEO) Ada Health (Group) Berlin (federal state)
Novorol, Claire (Ada Health 201712 CMO + Co-Founder) Chief Medical Officer (CMO) Ada Health (Group) Berlin (federal state)
Amado, Rafael (Adaptimmune 201503– CMO before GSK Head Oncology RnD) Chief Medical Officer (CMO) Adaptimmune (Group) South East England (region)
Bertrand, William (Bill), Jr. (Adaptimmune 201703– COO before MedImmne + Infinity Pharmaceuticals + Salix) Chief Operating Officer (COO) Adaptimmune (Group) South East England (region)
Desprez, Sébastian (Adaptimmune 201710– VP Communications + IR before ViiV Healthcare + GSK) Public Relations Manager / Investor Relations Manager Adaptimmune (Group) South East England (region)
Gerry, Andrew (Adaptimmune 201511 Director Preclinical Research) Research & Development Manager Adaptimmune (Group) South East England (region)
Henry, Margaret (Adaptimmune 201505 Head of PR) Public Relations Manager / Investor Relations Manager Adaptimmune (Group) South East England (region)
Miller, Juli P. (Adaptimmune 201808 Director Investor Relations) Public Relations Manager / Investor Relations Manager Adaptimmune (Group) South East England (region)
Noble, James (Adaptimmune CEO before MediGene 200609–200809 before Avidex) Chief Executive Officer (CEO) Adaptimmune (Group) South East England (region)
Peterson, Kristine (Valeritas + JnJ + Biovail + BMS) Board member, non-executive Adaptimmune (Group) South East England (region)
Rawcliffe, Adrian (Ad) (Adaptimmune 201503– CFO before GSK) Chief Financial Officer (CFO) Adaptimmune (Group) South East England (region)
1 2 3 ... 33 34 35  next pagenext page



Advertisement

Picture EBD Group Bio-Europe 2018 Copenhagen Denmark November 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnering Open 600x60px

» top